Bentham Science Logo

Track Your Manuscript:


Letters in Drug Design & Discovery

Volume 17, 12 Issues, 2020
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Letters in Drug Design & Discovery, Volume 9 - Number 9


In Vitro and In Vivo Investigations into the Carbene Silver Acetate Anticancer Drug Candidate SBC1

, 9(9): 815 - 822

Iduna Fichtner, Jindrich Cinatl, Martin Michaelis, Lara C. Sanders, Ralf Hilger, Breandan N. Kennedy, Alison L. Reynolds, Frauke Hackenberg, Grainne Lally, Susan J. Quinn, Ian McRae and Matthias Tacke


DOI: 10.2174/157018012803307987









Design of Peptidomimetic Based DPP-IV Inhibitors, Devoid of CYP Liabilities

, 9(9): 867 - 873

Pradip Jadav, Rajesh Bahekar, Shailesh R. Shah, Dipam Patel, Amit Joharapurkar, Kiran Shah, Shruti Bhardwaj, Kishan Patel, Kaushil Patel, Rajendra Chopade, Mubeen Shaikh, Kalapatapu V.V.M. Sairam and Mukul Jain


DOI: 10.2174/157018012803307932



Sesquiterpene Lactones with Anti-Hepatitis C Virus Activity Using Molecular Descriptors

, 9(9): 881 - 890

Michelle Rossini, Marcus Tullius Scotti, Mauro Vicentini Correia, Harold Hilarion Fokoue, Luciana Scotti, Francisco Jaime Bezerra Mendonca Junior, Marcelo Sobral da Silva and Vicente de Paulo Emerenciano


DOI: 10.2174/157018012803307969



Editor-in-Chief

K. Kuca
University of Hradec Kralove
Hradec Kralove
(Czech Republic)

Biography View Full Editorial Board

Journal History

Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.05

Advertisement

Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog